HIMS: Bullish after CorrectionHIMS has already shown a bullish reversal after a bottom of $14
Series of HH and HL are evident
Price is moving in an Ascending Parallel channel. However, breakdown of Ascending channel will activate bearish Flag pattern.
Entry now with tight SL (Low Risk High Reward Setup)
Trail your SL while t
Compare with Hims & Hers Health, Inc.
−0.05 USD
128.37 M USD
2.35 B USD
208.82 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
IPO date
Sep 9, 2019
ISIN
US4330001060
CUSIP
433000106
FIGI
BBG00Q53VYM7
Identifiers
ISIN US4330001060
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS – Rising Channel Breakdown: Correction Just Beginning?For several months, HIMS respected a well-defined rising channel, with buyers consistently stepping in at the lower boundary and driving higher highs.
That trend may now be changing.
Price has broken below the channel support, signaling that bullish momentum is fading and the market structure is w
$HIMS Hammer on the TrendlineBullish Thesis & Technical Theory
Higher-Low Trend Line Support:
The most compelling argument for a bullish reversal is the long-term ascending trend line. Price has pulled back sharply and is currently testing this exact structural boundary. This trend line has acted as a multi-month launching
HIMS Short — HIMS is losing steam below VWAP, and this rejectionHIMS is a strong short pullback candidate with a rejection trigger below VWAP and a wide reward/risk path back toward support. It is not excessively extended, and the aligned structure gives the downside setup enough room to act on technicals alone.
📍 Entry: 31.07
🛑 Stop: 33.29
🎯 Target: 24.24
⚖️ R
HIMS: Shorting the Retest [Setups by DefinedEdge]HIMS had been trending clean, stacking one consolidation on top of the next as it worked higher. We are looking to approach a very important level and today's pop back into that key level is giving what I think is a high quality short entry.
Here is the part that matters. The zone that broke sat ri
Chart Whisperer | Intuitive Market AnalysisI don’t look at the markets the way everyone else does. I consider myself a bit of a chart whisperer—not because I have a secret algorithm, but because years of staring at the screens have given me a deeply personal, intuitive feel for price action. My trading style is anchored in reading the natura
HIMS | May, 2026 | The time to go long has come- Timeframe: Weekly
- Trade type: Buy stop order
- Price: 26.64
- Take Profit: Open
- Stop Loss: 23.36 (-12.30 %)
Idea: Long on a breakout above last week's high — bullish momentum continuation.
Entry: Buy stop above last week’s high.
Stop-loss: Below the low of the same candle.
If the weekly candl
$HIMS — Breakout from converging triangle
The NYSE:HIMS chart is showing a breakout from a short-term converging triangle. This pattern suggests a potential continuation of the uptrend, but it's crucial to consider the nearby resistance level that has historically served as both support and resistance. The key points to watch are the con
Is Hims & Hers Disrupting Medicine or Chasing a Bubble?Hims & Hers Health sits at the intersection of consumer technology and clinical care. The stock recently hit fresh 2026 highs. Canaccord Genuity boosted its price target to $40. Meanwhile, a massive $400 million JPMorgan facility unlocks unparalleled corporate liquidity. This digital platform faces
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMay 15, 2030
Coupon0% (Zero)
See all HIMS bonds
Frequently asked questions
The current price of HIMS is 31.59 USD — it has increased by 6.51% in the past 24 hours. Watch Hims & Hers Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
HIMS stock has risen by 14.96% compared to the previous week, the month change is a −10.59% fall, over the last year Hims & Hers Health, Inc. has showed a −38.97% decrease.
We've gathered analysts' opinions on Hims & Hers Health, Inc. future price: according to them, HIMS price has a max estimate of 40.00 USD and a min estimate of 21.00 USD. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. stock forecast: see what analysts think of Hims & Hers Health, Inc. and suggest that you do with its stocks.
HIMS reached its all-time high on Feb 19, 2025 with the price of 72.98 USD, and its all-time low was 2.72 USD and was reached on May 12, 2022. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 6.91% volatile and has beta coefficient of 2.32. Track Hims & Hers Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. there?
Today Hims & Hers Health, Inc. has the market capitalization of 7.31 B, it has decreased by −7.45% over the last week.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. is going to release the next earnings report on Aug 10, 2026. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are −0.40 USD per share, whereas the estimation was 0.03 USD resulting in a −1.68 K% surprise. The estimated earnings for the next quarter are −0.05 USD per share. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 608.10 M USD, despite the estimated figure of 616.84 M USD. In the next quarter, revenue is expected to reach 698.90 M USD.
HIMS net income for the last quarter is −92.11 M USD, while the quarter before that showed 20.60 M USD of net income which accounts for 0.00% change. Track more Hims & Hers Health, Inc. financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 9, 2026, the company has 2.44 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is 115.48 M USD, and current EBITDA margin is 7.50%. See more stats in Hims & Hers Health, Inc. financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. stock shows the buy signal. See more of Hims & Hers Health, Inc. technicals for a more comprehensive analysis.









